The differential clinical impact of human coronavirus species in children with cystic fibrosis

Journal of Infectious Diseases

Volumn 206, Issue 3, 2012, Pages 384-388

  Da Silva Filho, Luiz Vicente Ribeiro Ferreira ^a   Zerbinati, Rodrigo Melim ^a   Tateno, Adriana Fumie ^a   Boas, Lucy Vilas ^a   De Almeida, Marina Buarque ^a   Levi, José Eduardo ^a   Drexler, Jan Felix ^b   Drosten, Christian ^b   Pannuti, Cláudio Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CORONAVIRUS; CORONAVIRUS INFECTION; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN CORONAVIRUS 229E; HUMAN CORONAVIRUS HKU1; HUMAN CORONAVIRUS NL63; HUMAN CORONAVIRUS OC43; INFANT; MAJOR CLINICAL STUDY; MALE; NEIGHBOR JOINING METHOD; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHYLOGENETIC TREE; PRESCHOOL CHILD; PRIORITY JOURNAL; RHINOVIRUS; SCHOOL CHILD; UPPER RESPIRATORY TRACT INFECTION; VIRUS IDENTIFICATION;

ADOLESCENT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CORONAVIRUS; CORONAVIRUS INFECTIONS; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; NASOPHARYNX; PHYLOGENY; RNA REPLICASE;

EID: 84863913456     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis274     Document Type: Article

References (15)

1. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003; 361:681-9.
2. Wat D, Gelder C, Hibbitts S, et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008; 7:320-8.
3. de Almeida MB, Zerbinati RM, Tateno AF, et al. Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. Emerg Infect Dis 2010; 16:996-9.
4. McIntosh K, Chao RK, Krause HE, Wasil R, Mocega HE, Mufson MA. Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis 1974; 130:502-7.
5. Fielding BC. Human coronavirus NL63: a clinically important virus? Future Microbiol 2011; 6:153-9.
6. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967-76.
7. van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10:368-73.
8. Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005; 79:884-95.
9. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 2010; 48:2940-7.
10. Talbot HK, Shepherd BE, Crowe JE Jr, et al. The pediatric burden of human coronaviruses evaluated for twenty years. Pediatr Infect Dis J 2009; 28:682-7.
11. Arden KE, Nissen MD, Sloots TP, Mackay IM. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol 2005; 75:455-62.
12. Kupfer B, Simon A, Jonassen CM, et al. Two cases of severe obstructive pneumonia associated with an HKU1-like coronavirus. Eur J Med Res 2007; 12:134-8.
13. Olesen HV, Nielsen LP, Schiotz PO. Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic. Pediatr Pulmonol 2006; 41:1197-204.
14. Wevers BA, van der Hoek L. Renin-angiotensin system in human coronavirus pathogenesis. Future Virol 2010; 5:145-61.
15. Arkwright PD, Pravica V, Geraghty PJ, et al. End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am J Respir Crit Care Med 2003; 167:384-9.